Bitpanda

Invest in Hikma Pharmaceuticals (hik)

Bitpanda makes it easy for you to invest in Hikma Pharmaceuticals from as little as €1. Invest 24/7 with zero commissions and tight spreads.

*Bitpanda Stocks are contracts replicating an underlying stock or ETF.

Get started

Hikma Pharmaceuticals

* Bitpanda Stocks are contracts replicating an underlying stock or ETF.

How to invest in Hikma Pharmaceuticals

With Bitpanda, you can invest in Hikma Pharmaceuticals easily, quickly and securely.
1

Sign up to Bitpanda

Create a Bitpanda account and confirm your email address.

2

Verify and deposit funds

Confirm your identity with one of our trusted verification partners and deposit funds.

3

Start investing in Hikma Pharmaceuticals

You’re all set! Start investing with Bitpanda Stocks in Hikma Pharmaceuticals and over 2,500 other digital assets.

Invest in Hikma Pharmaceuticals now

About Hikma Pharmaceuticals (HIK)

Hikma Pharmaceuticals Plc engages in developing, manufacturing and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd. and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.

Analyst ratings

%

Buy

Hold

Sell

Based on analysts ratings

Buy

Hold

Sell

Last updated:
Data provided by FactSet. This information does not constitute investment advice.

Hikma Pharmaceuticals market stats

Market cap
Daily high
Daily low
Volatility (1M)
Net income
Dividend yield
P/E ratio
Dividend per share
Earnings per share
Revenue

Downloads

To view older versions of these documents, click here
* Bitpanda Stocks are contracts replicating an underlying stock or ETF.

The website uses cookies.

We use cookies to optimize our services. The information we collect is used by us as part of our EU-wide activities. Cookie policy
Cookie settings
  • Essential cookies

    Always active

    As the name would suggest, some cookies on our website are essential. They are necessary to remember your settings when using Bitpanda, (such as privacy or language settings), to protect the platform from attacks, or simply to stay logged in after you originally log in. You have the option to refuse, block or delete them, but this will significantly affect your experience using the website and not all our services will be available to you.

  • Performance cookies
    Active Inactive

    We use such cookies and similar technologies to collect information as users browse our website to help us better understand how it is used and then improve our services accordingly. It also helps us measure the overall performance of our website. We receive the date that this generates on an aggregated and anonymous basis. Blocking these cookies and tools does not affect the way our services work, but it does make it much harder for us to improve your experience.

  • Advertisement cookies
    Active Inactive

    These cookies are used to provide you with adverts relevant to Bitpanda. The tools for this are usually provided by third parties. With the help of these cookies and such third parties, we can ensure for example, that you don’t see the same ad more than once and that the advertisements are tailored to your interests. We can also use these technologies to measure the success of our marketing campaigns. Blocking these cookies and similar technologies does not generally affect the way our services work. Please note, however, that while you’ll still see advertisements about Bitpanda on websites, the adverts will no longer be personalised for you.

Settings